|
1
|
Raab-Traub N: Epstein-Barr virus in the
pathogenesis of NPC. Semin Cancer Biol. 12:431–441. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Breda E, Catarino RJ, Azevedo I, Lobão M,
Monteiro E and Medeiros R: Epstein-Barr virus detection in
nasopharyngeal carcinoma: Implications in a low-risk area. Braz J
Otorhinolaryngol. 76:310–315. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chia WK, Teo M, Wang WW, Lee B, Ang SF,
Tai WM, Chee CL, Ng J, Kan R, Lim WT, et al: Adoptive T-cell
transfer and chemotherapy in the first-line treatment of metastatic
and/or locally recurrent nasopharyngeal carcinoma. Mol Ther.
22:132–139. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kavitha N, Vijayarathna S, Jothy SL, Oon
CE, Chen Y, Kanwar JR and Sasidharan S: MicroRNAs: Biogenesis,
roles for carcinogenesis and as potential biomarkers for cancer
diagnosis and prognosis. Asian Pac J Cancer Prev. 15:7489–7497.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Esquela-Kerscher A and Slack FJ:
Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer.
6:259–269. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Xia H, Ng SS, Jiang S, Cheung WK, Sze J,
Bian XW, Kung HF and Lin MC: miR-200a-mediated downregulation of
ZEB2 and CTNNB1 differentially inhibits nasopharyngeal carcinoma
cell growth, migration and invasion. Biochem Biophys Res Commun.
391:535–541. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang LY, Ho-Fun Lee V, Wong AM, Kwong DL,
Zhu YH, Dong SS, Kong KL, Chen J, Tsao SW, Guan XY and Fu L:
MicroRNA-144 promotes cell proliferation, migration and invasion in
nasopharyngeal carcinoma through repression of PTEN.
Carcinogenesis. 34:454–463. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wong TS, Man OY, Tsang CM, Tsao SW, Tsang
RK, Chan JY, Ho WK, Wei WI and To VS: MicroRNA let-7 suppresses
nasopharyngeal carcinoma cells proliferation through downregulating
c-Myc expression. J Cancer Res Clin Oncol. 137:415–422. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Deng M, Tang H, Zhou Y, Zhou M, Xiong W,
Zheng Y, Ye Q, Zeng X, Liao Q, Guo X, et al: miR-216b suppresses
tumor growth and invasion by targeting KRAS in nasopharyngeal
carcinoma. J Cell Sci. 124:2997–3005. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zehavi L, Avraham R, Barzilai A, Bar-Ilan
D, Navon R, Sidi Y, Avni D and Leibowitz-Amit R: Silencing of a
large microRNA cluster on human chromosome 14q32 in melanoma:
Biological effects of mir-376a and mir-376c on insulin growth
factor 1 receptor. Mol Cancer. 11:442012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang L, Wu H, Wang L, Zhang H, Lu J, Liang
Z and Liu T: Asporin promotes pancreatic cancer cell invasion and
migration by regulating the epithelial-to-mesenchymal transition
(EMT) through both autocrine and paracrine mechanisms. Cancer Lett.
398:24–36. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xie X, Li YS, Xiao WF, Deng ZH, He HB, Liu
Q and Luo W: MicroRNA-379 inhibits the proliferation, migration and
invasion of human osteosarcoma cells by targetting EIF4G2. Biosci
Rep. 37:BSR20160542. 2017. View Article : Google Scholar
|
|
13
|
Khan S, Brougham CL, Ryan J, Sahrudin A,
O'Neill G, Wall D, Curran C, Newell J, Kerin MJ and Dwyer RM:
miR-379 regulates cyclin B1 expression and is decreased in breast
cancer. PLoS One. 8:e687532013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wilson SH, Bailey AM, Nourse CR, Mattei MG
and Byrne JA: Identification of MAL2, a novel member of the mal
proteolipid family, though interactions with TPD52-like proteins in
the yeast two-hybrid system. Genomics. 76:81–88. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cao Q, Chen J, Zhu L, Liu Y, Zhou Z, Sha
J, Wang S and Li J: A testis-specific and testis developmentally
regulated tumor protein D52 (TPD52)-like protein TPD52L3/hD55
interacts with TPD52 family proteins. Biochem Biophys Res Commun.
344:798–806. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Byrne JA, Frost S, Chen Y and Bright RK:
Tumor protein D52 (TPD52) and cancer-oncogene understudy or
understudied oncogene? Tumour Biol. 35:7369–7382. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang Z, Sun J, Zhao Y, Guo W, Lv K and
Zhang Q: Lentivirus-mediated knockdown of tumor protein D52-like 2
inhibits glioma cell proliferation. Cell Mol Biol(Noisy-le-grand).
60:39–44. 2014.PubMed/NCBI
|
|
18
|
Pan ZY, Yang Y, Pan H, Zhang J, Liu H,
Yang Y, Huang G, Yin L, Huang J and Zhou WP: Lentivirus-mediated
TPD52L2 depletion inhibits the proliferation of liver cancer cells
in vitro. Int J Clin Exp Med. 8:2334–2341. 2015.PubMed/NCBI
|
|
19
|
Inoguchi S, Seki N, Chiyomaru T, Ishihara
T, Matsushita R, Mataki H, Itesako T, Tatarano S, Yoshino H, Goto
Y, et al: Tumour-suppressive microRNA-24-1 inhibits cancer cell
proliferation through targeting FOXM1 in bladder cancer. FEBS Lett.
588:3170–3179. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Han G, Fan M and Zhang X: microRNA-218
inhibits prostate cancer cell growth and promotes apoptosis by
repressing TPD52 expression. Biochem Biophys Res Commun.
456:804–809. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li G, Yao L, Zhang J, Li X, Dang S, Zeng
K, Zhou Y and Gao F: Tumor-suppressive microRNA-34a inhibits breast
cancer cell migration and invasion via targeting oncogenic TPD52.
Tumour Biol. 37:7481–7491. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Goto Y, Nishikawa R, Kojima S, Chiyomaru
T, Enokida H, Inoguchi S, Kinoshita T, Fuse M, Sakamoto S, Nakagawa
M, et al: Tumour-suppressive microRNA-224 inhibits cancer cell
migration and invasion via targeting oncogenic TPD52 in prostate
cancer. FEBS Lett. 588:1973–1982. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jin H, Yu Y, Hu Y, Lu C, Li J, Gu J, Zhang
L, Huang H, Zhang D, Wu XR, et al: Divergent behaviors and
underlying mechanisms of cell migration and invasion in
non-metastatic T24 and its metastatic derivative T24T bladder
cancer cell lines. Oncotarget. 6:522–536. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ren Y, Qiu H, Yuan Y, Ye J, Tian Y, Wen B,
Zhang W and Li Q: Evaluation of 7th edition of AJCC staging system
for nasopharyngeal carcinoma. J Cancer. 8:1665–1672. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Baer C, Claus R and Plass C: Genome-wide
epigenetic regulation of miRNAs in cancer. Cancer Res. 73:473–477.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chang ET and Adami HO: The enigmatic
epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol
Biomarkers Prev. 15:1765–1777. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li Z, Shen J, Chan MT and Wu WK:
MicroRNA-379 suppresses osteosarcoma progression by targeting PDK1.
J Cell Mol Med. 21:315–323. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gururajan M, Josson S, Chu GC, Lu CL, Lu
YT, Haga CL, Zhau HE, Liu C, Lichterman J, Duan P, et al: miR-154*
and miR-379 in the DLK1-DIO3 microRNA mega-cluster regulate
epithelial to mesenchymal transition and bone metastasis of
prostate cancer. Clin Cancer Res. 20:6559–6569. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Iorio MV, Ferracin M, Liu CG, Veronese A,
Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M,
et al: MicroRNA gene expression deregulation in human breast
cancer. Cancer Res. 65:7065–7070. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bhattacharyya SN, Habermacher R, Martine
U, Closs EI and Filipowicz W: Relief of microRNA-mediated
translational repression in human cells subjected to stress. Cell.
125:1111–1124. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Shehata M, Bièche I, Boutros R,
Weidenhofer J, Fanayan S, Spalding L, Zeps N, Byth K, Bright RK,
Lidereau R and Byrne JA: Nonredundant functions for tumor protein
D52-like proteins support specific targeting of TPD52. Clin Cancer
Res. 14:5050–5060. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Byrne JA, Maleki S, Hardy JR, Gloss BS,
Murali R, Scurry JP, Fanayan S, Emmanuel C, Hacker NF, Sutherland
RL, et al: MAL2 and tumor protein D52 (TPD52) are frequently
overexpressed in ovarian carcinoma, but differentially associated
with histological subtype and patient outcome. BMC Cancer.
10:4972010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Dasari C, Yaghnam DP, Walther R and
Ummanni R: Tumor protein D52 (isoform 3) contributes to prostate
cancer cell growth via targeting nuclear factor-κB transactivation
in LNCaP cells. Tumour Biol. 39:10104283176983822017. View Article : Google Scholar : PubMed/NCBI
|
